Telaprevir Patent Expiration

Telaprevir is Used for treating chronic hepatitis C. It was first introduced by Vertex Pharmaceuticals Inc in its drug Incivek on May 23, 2011.

Telaprevir Patents

Given below is the list of patents protecting Telaprevir, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Incivek	US8431615	Dose forms	May 30, 2028	Vertex Pharms
Incivek	US7820671	Peptidomimetic protease inhibitors	Feb 25, 2025 (Expired)	Vertex Pharms
Incivek	US8529882	Peptidomimetic protease inhibitors	Aug 31, 2021 (Expired)	Vertex Pharms

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List